Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

Indexed by

Indexed by DOAJ

Article Access statistics

Viewed: 233

Emailed: 0

PDF Downloaded: 232

Panacea Journal of Medical Sciences


Assessment of cardiovascular risk due to dyslipidemia by framingham score and using this information for early initiation of treatment of hypothyroidism and reducing the risk for cardiovascular events


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Puneet Goyal, Ankit Meshram*

Volume : 11, Issue : 1, Year : 2021

Article Page : 82-85

https://10.18231/j.pjms.2021.019

Article Metrics



Suggest article by email


Abstract

Materials and Methods: This study was planned and carried out in The Department of Medicine M.G.M. Medical College and M.Y. Hospital Indore, patients with subclinical Hypothyroidism not taking any treatment and patients of overt hypothyroidism not taking treatment coming to the OPD.
Study Design: Observational Study.
Result: In normal subject, the mean Framingham score was 0.89 0.57%, while in subclinical hypothyroidism patients it was 1.78 1.4% mg/dL showing a higher mean Framingham score in subclinical hypothyroidism patients as compared to normal subjects and the difference was found to be statistically significant (P<0> hypothyroidism patients as compared to normal subjects and the difference came out to be statistically significant (P<0> Conclusion: Overt and subclinical hypothyroidism both are associated with increased cardiovascular risk indicated by the higher values of Framingham risk in these patients as compared to normal controls. Mean Framingham risk was 3.31 2.82% in overt hypothyroidism patients, 1.78 1.4% in subclinical hypothyroidism and 0.89 0.57% in normal controls all of which were statistically significant[P<0>

Keywords: Cardiovascular, Dyslipidemia, Hypothyroidism & Framingham, Score.


How to cite : Goyal P , Meshram A , Assessment of cardiovascular risk due to dyslipidemia by framingham score and using this information for early initiation of treatment of hypothyroidism and reducing the risk for cardiovascular events. Panacea J Med Sci 2021;11(1):82-85

Copyright © 2021 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)